Benzinga.com5h
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
In July, the FDA rejected Novo Nordisk's BLA filing for the once-weekly insulin icodec. Insulin pens, known for their dosing accuracy and user-friendly design, have been preferred by 82% of surveyed ...